Additionally, comorbidities such as diabetes, hypertension and coronary disease and factors such as age, procalcitonin and interleukin (IL)-6 levels, leukocytosis and lymphocytopenia have been included as associated with mortality in patients with COVID-19 9, 14. This evidence concerns the gene IL6 and COVID-19.